Menu
Recruiting NCT07267871

Oura Blood Pressure Profile Study

— Observational Hypertension High Blood Pressure

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Hypertension, High Blood Pressure. Basic parameters: from 22 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Oura Blood Pressure Profile Study: An Evaluation of the Oura Blood Pressure Profile Algorithm for Identifying Signs of Hypertension

Overview

The proposed study is designed as a prospective, single-arm, observational, non-significant risk device study to evaluate the performance of Oura's investigational Blood Pressure Profile algorithm in identifying signs of hypertension.

Primary outcome measures

  • Sensitivity of the Oura Blood Pressure Profile classification for identifying participant-reported hypertension [Time frame: From enrollment until up to 18 months]
Secondary outcome measures (1)
  • Specificity of the Oura Blood Pressure Profile classification versus participant-reported hypertension [Time frame: From enrollment until up to 18 months]

Eligibility criteria

Inclusion criteria

  • Located in United States
  • Aged 22 years or older at time of eligibility screener
  • Oura Ring user (Oura Ring Gen3 or newer)
  • User of the English version of the Oura App
  • Smartphone (iOS or Android) user
  • Able to provide consent electronically

Exclusion criteria

  • User of implanted cardiac electronic device(s)
  • Currently pregnant
  • Within 12 weeks postpartum

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Cohort

Study locations

United States · 1 center
  • Ouraring — San Francisco

Identifiers

NCT: NCT07267871 · HTN-2025

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗